Bavarian will market Covid-19 vaccine on its own – but doesn't rule out future partners
![Paul Chaplin, CEO of Bavarian Nordic | Photo: Bavarian Nordic /PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14000817.ece/ALTERNATES/schema-16_9/doc7kwzzhztf02q9kn31fl.jpg)
There’s no shortage of competition on the Covid-19 vaccine market, and things aren’t made easier for Danish biotech firm Bavarian Nordic by competitors being some of the biggest players in the world – remaining so even after a year and some time since the first vaccines against Covid-19 hit the market.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.